Dementia, mild
Clinical trials for Dementia, mild explained in plain language.
Never miss a new study
Get alerted when new Dementia, mild trials appear
Sign up with your email to follow new studies for Dementia, mild, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill xanamem aims to slow Alzheimer's decline
Disease control OngoingThis study tests whether a daily 10 mg pill called Xanamem can safely slow memory and function loss in people with mild or moderate Alzheimer's dementia. About 247 participants will receive either Xanamem or a placebo for 36 weeks, with an option to continue the drug for up to 10…
Matched conditions: DEMENTIA, MILD
Phase 2/3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
App could revolutionize dementia screening in primary care
Diagnosis OngoingThis study tests a new app called RACS that helps primary care doctors screen older adults for early cognitive decline. The app includes risk questions, a symbol matching task, and voice tasks. Researchers will enroll 500 adults aged 60 and older to see if the tool is easy to use…
Matched conditions: DEMENTIA, MILD
Sponsor: University of Texas at Austin • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
A new web tool aims to ease tough tech decisions for dementia families
Knowledge-focused OngoingThis trial tests whether a web-based tool called 'Let's Talk Tech' helps people with mild dementia or mild cognitive impairment and their care partners feel more prepared to make decisions about using technology for home care and safety. Participants use the tool together for up …
Matched conditions: DEMENTIA, MILD
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Brain health study tests personalized coaching for memory decline prevention
Knowledge-focused OngoingThis study looks at whether giving older adults (ages 60-79) personalized advice and extra support helps them follow brain-healthy habits like a Mediterranean diet, exercise, and staying socially active. Participants have mild memory concerns or are at risk for cognitive decline.…
Matched conditions: DEMENTIA, MILD
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Brain scans track tau changes after Alzheimer's antibody treatment
Knowledge-focused By invitation onlyThis study uses special brain scans (tau PET) to see how anti-amyloid immunotherapy affects tau protein buildup in people with mild Alzheimer's disease. About 135 participants will get two tau PET scans—one before starting treatment and another 12-18 months after finishing it. Th…
Matched conditions: DEMENTIA, MILD
Phase 2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC